The suggestion that some colorectal cancers (CRCs) develop by a methylation pathway has been given support by a genetic study of 500 patients in Australia. The findings support the view that key enzymes in the metabolism of folate and methyl groups, which affect DNA methylation, influence predisposition to CRCs, particularly …